Related Experiment Video
Updated: Jun 7, 2025

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
Lung function trajectories in common variable immunodeficiencies: An observational retrospective multicenter study
Helena Buso1, Davide Firinu2, Renato Finco Gambier1
1Department of Medicine, DIMED, University of Padova, Padova, Italy; Internal Medicine 1, Ca' Foncello University Hospital, AULSS2, Treviso, Italy.
Patients with common variable immunodeficiencies (CVIDs) often have reduced lung function, but their lung decline is not accelerated after diagnosis. This study analyzed lung physiology in CVIDs, finding most had lower lung volumes but a stable decline rate.
Area of Science:
- Pulmonology
- Immunology
- Internal Medicine
Background:
- Respiratory disease is a significant cause of illness and death in common variable immunodeficiencies (CVIDs).
- Lung function trajectories in CVIDs are not well understood, necessitating further investigation.
Purpose of the Study:
- To determine lung physiology measurements in patients with CVIDs.
- To analyze the temporal trajectory of lung function in CVIDs.
- To investigate the association between lung function and clinical/immunologic parameters in CVIDs.
Main Methods:
- Retrospective analysis of longitudinal pulmonary function tests (PFTs) and chest CT scans from 185 CVID patients across 5 Italian centers.
- PFTs were standardized using the European Respiratory Society/American Thoracic Society 2021 guidelines, expressing results as percentiles within a healthy population's normal distribution.
- Investigated associations between lung function parameters (FEV1, FVC) and clinical/immunologic factors, including switched-memory B cell counts.
Main Results:
- The majority of CVID patients exhibited lung volumes in the lower third of the normal distribution; 23% had FEV1 < lower limit of normal (LLN) and 21% had FVC < LLN.
- Low switched-memory B cells (<2%) were significantly associated with reduced FEV1 (OR 7.58) and FVC (OR 3.55).
- In patients with at least 5 years of PFT data, the annual decline in FEV1 (25.6 mL/year) and FVC (15.6 mL/year) did not differ significantly from predicted rates.
Conclusions:
- Most patients with CVIDs present with lung volumes below the median of healthy individuals.
- The rate of lung function decline in CVID patients is not accelerated post-diagnosis, suggesting a stable disease course in terms of pulmonary function.
- Identifying immunologic markers like switched-memory B cells may help predict lung function impairment in CVIDs.
Related Concept Videos
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Pulmonary Function Tests
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...

